PharmaJet® and Immuno Cure Sign Agreement for Clinical Development of a Needle-free HIV Therapeutic DNA Vaccine
GOLDEN, Colo.–(BUSINESS WIRE)–PharmaJet®, a company that strives to improve the performance and outcomes of injectables with its enabling needle-free injection technology, today announced that it has entered into an agreement with Immuno Cure, a prominent developer of DNA vaccines. Under... Read More →
Bloom Standard expands access to infant ultrasound for faster diagnosis and better outcomes
Patient Stories: How MedTech Innovator alumni are transforming lives At MedTech Innovator, we empower healthtech companies to bring groundbreaking solutions to patients in need. Our Patient Stories series highlights the real-world clinical impact of the companies we support—showcasing how their... Read More →
Neuspera Medical Receives FDA Approval for First Integrated Sacral Neuromodulation (iSNM) System for Urinary Urge Incontinence
SAN JOSE, Calif., June 18, 2025 /PRNewswire/ — Neuspera® Medical, Inc., the leading developer of integrated technologies powering the future of neuromodulation, today announced that the U.S. Food and Drug Administration (FDA) has approved its integrated sacral neuromodulation (iSNM) system... Read More →
Mount Sinai adopts Flosonics wearable ultrasound device
Flosonics announced today that Mount Sinai Hospital has adopted FloPatch, its wireless Doppler ultrasound device. Mount Sinai (New York), one of the top hospitals in the U.S., adopted FloPatch in its surgical and transplant intensive care unit (ICU). The company... Read More →
Backed by $2 Million, Droplet IV is Set to Launch its Revolutionary Automatic IV-Line Flushing Device in EU & US in 2026
Copenhagen, Denmark – June 10, 2025 – Droplet IV today announced the successful completion of a $2 million funding round to enable launch of its first automatic IV-line flushing device in the EU and US markets. The device addresses a... Read More →
bioMérieux strengthens its next-generation sequencing capabilities with the acquisition of Day Zero Diagnostics solutions and technologies
Marcy l’Étoile, France – June 16th, 2025 – bioMérieux, a world leader in the field of in vitro diagnostics, announces an agreement to acquire the assets of Day Zero Diagnostics, a US-based infectious disease diagnostics company using genome sequencing and... Read More →
Alva Health Wins $500,000 in R&D Funding from the U.S. National Science Foundation
DALLAS, TX, UNITED STATES, June 12, 2025 /EINPresswire.com/ — Alva Health, a medical device company pioneering wearable solutions for early stroke detection, has been awarded $500,000 from the U.S. National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase IIB... Read More →
Moon Surgical Discusses Maestro at NVIDIA GTC Paris, Celebrating 1,300+ Procedures in the Past Year and the Power of Physical AI
PARIS and SAN FRANCISCO, June 12, 2025 /PRNewswire/ — Moon Surgical, the French-American leader in Physical AI for the operating room, today announced its participation at NVIDIA GTC Paris during VivaTech2025. In collaboration with NVIDIA, Moon Surgical is highlighting the... Read More →
Neurent Medical Announces 510(k) Clearance of its Next Generation NEUROMARK® System
Galway, Ireland – June 11, 2025 — Neurent Medical, a leader in pioneering non-surgical solutions for chronic sino-nasal inflammatory diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s Next Generation NEUROMARK®... Read More →
Huntsville Memorial Hospital Reduces Patient Transfers and Enhances Local Care with Onsite EEG Program Powered by Zeto
HUNTSVILLE, Texas, June 11, 2025 /PRNewswire/ — Zeto, Inc. is proud to announce the success of a new onsite EEG program at Huntsville Memorial Hospital (HMH) that has helped reduce emergency room patient transfers and improve access to neurological diagnostics... Read More →